Effect of black raisin consumption on some cardiovascular risk factors

Effect of black Raisin consumption on some cardiovascular risk factors, serum alonaldehyde and total antioxidant capacity in hyperlipidemic patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015091624049N1

Enrollment

Registered

2015-10-27

Start date

2015-09-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperlepidemia. Disorders of lipoprotein metabolism and other lipidaemias

Interventions

Intervention 1: intervention group consume 90 grams black raisin daily for 5 weeks and Amount of energy and macronutrients that are received via raisins are Replaced in intervention group Dietary. I

intervention group consume 90 grams black raisin daily for 5 weeks and Amount of energy and macronutrients that are received via raisins are Replaced in intervention group Dietary.

The control group receives no intervention

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Hypercholesterolemia patients who have high cholesterol of 200 mg dL or triglyceride levels over 200 milligrams per deciliter. Exclusion criteria: Hepatic or renal disorders, hypothyroidism and hyperthyroidism, myocardial infarction, diabetes, as well as samples that consume antioxidants, Pregnancy or hormone therapy in women

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Height. Timepoint: Baseline. Method of measurement: wall meter.;Blood pressure. Timepoint: at baseline and 5 weeks after the intervention. Method of measurement: Aneroid sphygmomanometer dial, bulb, and air valve.;Weight. Timepoint: at basline and 5 weeks after the intervention. Method of measurement: Kilogram and with digital weight scale.;Serum triglycerid. Timepoint: at basline and 5 weeks after the intervention. Method of measurement: Methods of enzymatic analysis.;Serum total cholesterol. Timepoint: at basline and 5 weeks after the intervention. Method of measurement: Methods of enzymatic analysis.;Serum levels of HDL. Timepoint: at basline and 5 weeks after the intervention. Method of measurement: Methods of enzymatic analysis.;Serum levels of LDL. Timepoint: at basline and 5 weeks after the intervention. Method of measurement: Friedewald formula.;Plasma levels of fibrinogen. Timepoint: at basline and 5 weeks after the intervention. Method of measurement: special kits and analyzer vicheles.;Plasma levels of coagulation factor VII. Timepoint: at basline and 5 weeks after the intervention. Method of measurement: Clotting time and spicial kit.;Serum levels of hs-CRP. Timepoint: at basline and 5 weeks after the intervention. Method of measurement: ELISA Kits.;TAC , serum total antioxidant capacity. Timepoint: at basline and 5 weeks after the intervention. Method of measurement: Colorimetric Test Kits.;MDA , Malondialdehyde. Timepoint: at basline and 5 weeks after the intervention. Method of measurement: TBARS.	—

Measure

Time frame

Height. Timepoint: Baseline. Method of measurement: wall meter.;Blood pressure. Timepoint: at baseline and 5 weeks after the intervention. Method of measurement: Aneroid sphygmomanometer dial, bulb, and air valve.;Weight. Timepoint: at basline and 5 weeks after the intervention. Method of measurement: Kilogram and with digital weight scale.;Serum triglycerid. Timepoint: at basline and 5 weeks after the intervention. Method of measurement: Methods of enzymatic analysis.;Serum total cholesterol. Timepoint: at basline and 5 weeks after the intervention. Method of measurement: Methods of enzymatic analysis.;Serum levels of HDL. Timepoint: at basline and 5 weeks after the intervention. Method of measurement: Methods of enzymatic analysis.;Serum levels of LDL. Timepoint: at basline and 5 weeks after the intervention. Method of measurement: Friedewald formula.;Plasma levels of fibrinogen. Timepoint: at basline and 5 weeks after the intervention. Method of measurement: special kits and analyzer vicheles.;Plasma levels of coagulation factor VII. Timepoint: at basline and 5 weeks after the intervention. Method of measurement: Clotting time and spicial kit.;Serum levels of hs-CRP. Timepoint: at basline and 5 weeks after the intervention. Method of measurement: ELISA Kits.;TAC , serum total antioxidant capacity. Timepoint: at basline and 5 weeks after the intervention. Method of measurement: Colorimetric Test Kits.;MDA , Malondialdehyde. Timepoint: at basline and 5 weeks after the intervention. Method of measurement: TBARS.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParvin Joola

Ahvaz University of Medical Sciences

joola.p@ajums.ac.ir+98 61 3373 8319

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 23, 2026